Found: 11
Select item for more details and to access through your institution.
Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1244, doi. 10.3390/ph14121244
- By:
- Publication type:
- Article
The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 3, p. 714, doi. 10.3390/ijms20030714
- By:
- Publication type:
- Article
AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 1, doi. 10.1007/s10637-017-0500-x
- By:
- Publication type:
- Article
Effects of histone deacetylase inhibitory prodrugs on epigenetic changes and DNA damage response in tumor and heart of glioblastoma xenograft.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 4, p. 412, doi. 10.1007/s10637-017-0448-x
- By:
- Publication type:
- Article
Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex).
- Published in:
- Clinical & Experimental Metastasis, 2008, v. 25, n. 7, p. 703, doi. 10.1007/s10585-008-9179-x
- By:
- Publication type:
- Article
Disparate Impact of Butyroyloxymethyl Diethylphosphate (AN-7), a Histone Deacetylase Inhibitor, and Doxorubicin in Mice Bearing a Mammary Tumor.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031393
- By:
- Publication type:
- Article
The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 1, p. 130, doi. 10.1007/s10637-010-9542-z
- By:
- Publication type:
- Article
The selectivty and anti-metastatic activity of oral bioavailable butyric acid prodrugs.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 5, p. 383, doi. 10.1007/s10637-006-6213-1
- By:
- Publication type:
- Article
Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
- Published in:
- Journal of Cellular Biochemistry, 2018, v. 119, n. 4, p. 3417, doi. 10.1002/jcb.26512
- By:
- Publication type:
- Article
In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer.
- Published in:
- International Journal of Cancer, 2005, v. 116, n. 2, p. 226, doi. 10.1002/ijc.21030
- By:
- Publication type:
- Article
The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0146115
- By:
- Publication type:
- Article